P83.1

Clinical Causes: The exact cause of neonatal erythema toxicum is unknown, but it is believed to involve the normal development of a newborn's skin immune system. It is thought to result from the migration of immune cells into the skin as part of normal maturation after birth. Hormonal influences from the mother, which cross the placenta, may also play a role in its development. Genetic factors are not established, but the condition appears more frequently in full-term infants.

Key Symptoms: Presence of small, yellow or white pustules (blister-like bumps) on a red or pink base. The rash typically appears suddenly during the first week of life. Lesions are usually scattered across the face, chest, back, and limbs. The bumps are often surrounded by areas of erythema (redness). The rash is asymptomatic, meaning it does not cause discomfort or itching. Lesions tend to resolve spontaneously within a week or two without scarring.

Diagnosis Path: Diagnosis of neonatal erythema toxicum is primarily clinical, based on the characteristic appearance of the skin lesions. A healthcare provider will examine the newborn's skin and take into account the timing and distribution of the rash. In some cases, a gentle skin smear or cytology may be performed to confirm the presence of eosinophils, which are white blood cells commonly found in this condition. Typically, no laboratory tests are necessary, as the rash is benign and self-limiting.

Treatment Protocols: Since neonatal erythema toxicum is a benign and self-resolving condition, treatment is generally not required. Care involves keeping the affected skin clean and dry, and monitoring for any signs of secondary infection or other skin issues. Parents are advised to avoid using harsh soaps or irritating substances on the baby's skin. In rare cases where the rash persists or causes concern, consultation with a pediatric dermatologist may be helpful for further assessment and reassurance. The condition naturally resolves within 1 to 2 weeks without intervention.